An open-label, randomized, single intravenous dosing study to investigate the effect of fixed dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR)
dc.contributor.author | Walimbwa, Stephen Ian | |
dc.contributor.author | Kaboggoza, Julian Paul | |
dc.contributor.author | Waitt, Catriona | |
dc.contributor.author | Byakika-Kibwika, Pauline | |
dc.contributor.author | D'Avolio, Antonio | |
dc.contributor.author | Lamorde, Mohammed | |
dc.date.accessioned | 2022-01-12T07:53:39Z | |
dc.date.available | 2022-01-12T07:53:39Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Remdesivir is a novel broad-spectrum antiviral therapeutic with activity against several viruses that cause emerging infectious diseases. The purpose of this study is to explore how commonly utilized antiretroviral therapy (tenofovir disoproxil fumarate /lamivudine [TDF/3TC] and atazanavir/ritonavir [ATV/r]) influence plasma and intracellular concentrations of remdesivir. | en_US |
dc.identifier.citation | Walimbwa, S. I., Kaboggoza, J. P., Waitt, C., Byakika-Kibwika, P., D'Avolio, A., & Lamorde, M. (2021). An open-label, randomized, single intravenous dosing study to investigate the effect of fixed dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR). https://orcid.org/0000-0002-3825-3260 | en_US |
dc.identifier.uri | https://orcid.org/0000-0002-3825-3260 | |
dc.identifier.uri | https://nru.uncst.go.ug/xmlui/handle/123456789/1200 | |
dc.language.iso | en | en_US |
dc.publisher | Research Square | en_US |
dc.subject | Remdesivir | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Ebola | en_US |
dc.subject | HIV | en_US |
dc.subject | Atazanavir | en_US |
dc.subject | Ritonavir | en_US |
dc.subject | Tenofovir | en_US |
dc.subject | Lamivudine | en_US |
dc.subject | Drug-drug interactions | en_US |
dc.title | An open-label, randomized, single intravenous dosing study to investigate the effect of fixed dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR) | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- An open-label, randomized, single intravenous rs.pdf
- Size:
- 860.37 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: